Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from CVS Group plc ( (GB:CVSG) ) is now available.
CVS Group plc, the AIM-listed veterinary services provider with extensive operations across the UK and Australia, has continued to expand its integrated model of veterinary practices, laboratories and online retail, positioning itself as a major player in companion animal healthcare. The company disclosed that it repurchased 11,110 ordinary shares on 23 December 2025 under its ongoing share buyback programme, at prices between 1,264p and 1,274p per share and a volume-weighted average of 1,271.04p, and intends to cancel all of these shares, reducing the number of shares in issue to 70,742,004 with no treasury shares held. Since launching the buyback on 24 October 2025, CVS has bought back a total of 998,779 shares at an average price of 1,219.39p, a move that tightens its share capital and may enhance earnings per share, while updating investors on the new total voting rights figure used for regulatory disclosure thresholds.
The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1320.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.
Spark’s Take on GB:CVSG Stock
According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.
CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.
To see Spark’s full report on GB:CVSG stock, click here.
More about CVS Group plc
CVS Group plc is an AIM-listed provider of veterinary services with operations in the UK and Australia, focused on delivering high-quality clinical care through a network of around 470 veterinary practices, including specialist referral hospitals and out-of-hours sites. Beyond its core practices division, the Group also runs diagnostic laboratories serving both in-house and third-party clients, as well as an online pet retail business, Animed Direct, and employs approximately 8,900 staff, including about 2,400 veterinary surgeons and 3,300 nurses.
Average Trading Volume: 444,443
Technical Sentiment Signal: Buy
Current Market Cap: £891.9M
See more data about CVSG stock on TipRanks’ Stock Analysis page.

